Associated Papers
Somatic mutations in CCK2R alter receptor activity that promote oncogenic phenotypes.
Willard MD et al.
Molecular Cancer Research : Mcr, 2012
Insights into the cholecystokinin 2 receptor binding site and processes of activation.
Paillasse MR et al.
Molecular Pharmacology, 2006
High tumorigenic potential of a constitutively active mutant of the cholecystokinin 2 receptor.
Galés C et al.
Oncogene, 2003
Select a paper to view details